-
BI-D1870是ATP竞争性S6核糖体抑制剂，对RSK1/2/3/4的IC50分别为31 nM/24 nM/18 nM/15 nM，比对MST2，GSK-3β，MARK3，CK1 和Aurora B的抑制性高10到100倍。
More
-
Doxorubicin (Adriamycin)是一种抗生素类试剂，能够抑制DNA拓扑异构酶II，且诱导DNA损伤和凋亡。
More
-
Sorafenib (BAY 43-9006), an orally active multi-kinase inhibitor, targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Sorafenib是Raf-1, B-Raf和VEGFR-2等的多重激酶抑制剂，IC50分别为6 nM, 22 nM和90 nM。
More
-
Natural triterpenoid that displays anti-HIV and antitumor activity. Induces the production of reactive oxygen species (ROS) and activates NF-κB. Exhibits GPBA receptor agonist activity (EC50 = 1.04 μM).
More
-
(S)-10-Hydroxycamptothecin 是临床治疗肝癌的有效试剂。
More
-
BI-D1870是ATP竞争性S6核糖体抑制剂，对RSK1/2/3/4的IC50分别为31 nM/24 nM/18 nM/15 nM，比对MST2，GSK-3β，MARK3，CK1 和Aurora B的抑制性高10到100倍。
More
-
Doxorubicin (Adriamycin)是一种抗生素类试剂，能够抑制DNA拓扑异构酶II，且诱导DNA损伤和凋亡。
More
-
Sorafenib (BAY 43-9006), an orally active multi-kinase inhibitor, targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Sorafenib是Raf-1, B-Raf和VEGFR-2等的多重激酶抑制剂，IC50分别为6 nM, 22 nM和90 nM。
More
-
Natural triterpenoid that displays anti-HIV and antitumor activity. Induces the production of reactive oxygen species (ROS) and activates NF-κB. Exhibits GPBA receptor agonist activity (EC50 = 1.04 μM).
More
-
(S)-10-Hydroxycamptothecin 是临床治疗肝癌的有效试剂。
More
